Barclays Upgrades Sotera Health (SHC) to Overweight

Barclays analyst Luke Sergott upgraded Sotera Health (NASDAQ: SHC) from Underweight to Overweight with a price target of $22.00 (from $6.00).

For an analyst ratings summary and ratings history on Sotera Health click here. For more ratings news on Sotera Health click here.

Shares of Sotera Health closed at $8.64 yesterday.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Semiconductor Manufacturing International Corp. (981:HK) (SMI) PT Raised to HK$153 at Goldman Sachs
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings